Iraj Alipourfard | Biomedical Sciences | Best Researcher Award

Dr. Iraj Alipourfard | Biomedical Sciences | Best Researcher Award 

Researcher, at Institute of Physical Chemistry Polish Academy of Sciences, Poland.

Summary

Dr. Iraj Alipourfard is a distinguished researcher and educator specializing in biomedical sciences, nanotechnology, and tissue engineering. Currently serving as a Postdoctoral Research Associate at the Institute of Physical Chemistry, Polish Academy of Sciences, he contributes to groundbreaking projects in organ-on-chip systems, regenerative therapy, and nanoparticle applications. With over 20 years of experience in academia and clinical practice, Dr. Alipourfard has lectured in biochemistry, molecular biology, and pharmacology across institutions in Iran, Armenia, and Poland. His multidisciplinary expertise spans cell encapsulation, microfluidics, and advanced molecular diagnostics. A prolific author and reviewer, he is also a martial arts champion with a black belt in judo.

Professional Profile

Scopus

Google Scholar

ORCID

Education

🎓 Dr. Alipourfard holds a Master of Science in Medical Analytic Laboratory Sciences from Tehran University of Medical Sciences (2005), where his thesis explored genetic disruptions in Saccharomyces cerevisiae. He completed a postdoctoral training in Clinical Biochemistry at Iran University of Medical Sciences (2022). Additionally, he earned a Postgraduate Diploma in Nutrition from the University of Vocational Education, Poland (2022). His academic foundation integrates biomedical research with applied clinical diagnostics, preparing him for interdisciplinary innovations in biomedicine.

Experience

🧪 Dr. Alipourfard is currently a Postdoctoral Research Associate at the Institute of Physical Chemistry, Polish Academy of Sciences. His work involves developing microfluidics-assisted 3D cell cultures and encapsulated pancreatic hydrogels for regenerative therapies. Previously, he was a University Research Assistant at the University of Silesia, investigating gut microbiota’s role in diabetes. He also lectured in biochemistry and genetics at Yerevan Haybusak University and managed medical laboratories at hospitals in Iran. His expertise in biomedical laboratory techniques and academic instruction has been a cornerstone of his career.

Research Interests

🔬 Dr. Alipourfard’s research interests center on regenerative medicine, nanobiotechnology, and tissue engineering. He focuses on microfluidic systems for T-regulatory lymphocyte encapsulation, anti-bacteriophage nanoparticle synthesis, and organoid modeling for drug sensitivity assays. His work also explores the interplay of gut microbiota in diabetes and obesity. Passionate about translational science, Dr. Alipourfard aims to bridge the gap between bench research and clinical applications, especially in autoimmune therapy and cancer diagnostics.

Awards

🏆 Dr. Alipourfard’s accolades include the LazioDisco Italian Governmental Scholarship (2016–2018), the Erasmus Internship Award (2018–2019), and the Best Presentation Award at a Clinical Microbiology Conference in Shiraz, Iran. He also secured the First Ranking Position in the admission test for the Master of Pharmacy program at the University of Rome Tor Vergata. His diverse honors reflect his academic excellence, international collaborations, and impactful contributions to biomedical sciences.

Top Noted Publications

📚 Dr. Alipourfard has authored 65 scientific articles, two book chapters on cancer and nanotechnology, and numerous conference papers. Below are selected publications with hyperlinks:

  • “The Role of Akt Protein Kinase in Metabolic-Inflammatory Pathways Cross-Talk”
    Published in: Journal of Biochemistry, 2019

    • Cited by: 150 articles
    • This study investigates the interaction between Akt protein kinase and metabolic-inflammatory pathways, with an emphasis on how TNF-α regulation can improve insulin resistance in HepG2 cells. The research contributes to understanding the role of Akt in managing metabolic disorders.
  • “Molecular Evaluation of Methicillin-Resistant Staphylococcus aureus”
    Published in: Clinical Microbiology & Infection, 2010

    • Cited by: 300 articles
    • This article presents an in-depth molecular analysis of methicillin-resistant Staphylococcus aureus (MRSA), focusing on its genetic and antimicrobial resistance profiles. The findings provide significant insights into the epidemiology and molecular mechanisms of MRSA in healthcare settings.
  • “Nanomedicine: A New Frontier of Nanotechnology in Clinical Practice”
    Published in: Advanced Research in Physics Conference Proceedings, 2009

    • This paper explores the potential applications of nanomedicine, highlighting the transformative role of nanotechnology in diagnosing and treating diseases. The work sheds light on how nanomedicine could revolutionize clinical practices, enhancing therapeutic delivery and diagnostic capabilities.

Conclusion

Iraj Alipourfard is a highly qualified researcher with a robust portfolio of innovative research, practical applications, and academic teaching. His impressive list of awards, publications, and ongoing research projects positions him as an ideal candidate for the Best Researcher Award. With continued interdisciplinary collaboration and expansion of his research influence, he is poised to make even greater contributions to the scientific community.

 

Morteza Sadeghi | Biological Sciences | Best Researcher Award

Dr. Morteza Sadeghi, Biological Sciences, Best Researcher Award

Doctorate at University of isfahan, Iran

Summary:

Dr. Morteza Sadeghi is a highly accomplished biochemist with a solid educational background and extensive research experience. He obtained his Bachelor of Science in Cell and Molecular Biology from the Faculty of Science at the University of Kurdistan, Sanandaj, Iran, in 2015. Following this, he pursued a Master’s degree in Biochemistry from the same institution, completing it in 2018. Dr. Sadeghi further advanced his academic journey by earning a Ph.D. in Biochemistry from the Faculty of Biological Science and Technology, specializing in the Department of Cell and Molecular Biology and Microbiology, at the University of Isfahan, Iran, in 2022.

Throughout his academic career, Dr. Sadeghi has demonstrated a strong commitment to teaching and research. As an Undergraduate Teacher of Metabolism Biochemistry at the University of Isfahan, he contributed to the education of students. His research endeavors have led to publications in reputable journals, covering various aspects of biochemistry, medicinal chemistry, and molecular biology.

Dr. Morteza Sadeghi’s dedication to advancing knowledge in the field of biochemistry is reflected in his academic achievements and contributions to scientific research. His multidisciplinary expertise positions him as a valuable contributor to the scientific community.

Professional Profile:

Google Scholar Profile

👩‍🎓Education & Qualification:

2015: Bachelor of Science, Cell and Molecular Biology, Faculty of Science, University of Kurdistan, Sanandaj, Iran.

2018: M.Sc in Biochemistry, Faculty of Science, University of Kurdistan, Sanandaj, Iran.

2022: Ph.D. in Biochemistry, Faculty of Biological Science and Technology, Department of Cell and Molecular Biology and Microbiology, University of Isfahan, Isfahan, Iran.

Work Experience:

Dr. Morteza Sadeghi has valuable work experience as an Undergraduate teacher of Metabolism Biochemistry at the University of Isfahan. His role in this capacity extended from September 2019 to January 2020. During this period, Dr. Sadeghi likely contributed to the education and academic development of undergraduate students, sharing his knowledge and expertise in the field of Metabolism Biochemistry. His engagement in teaching underscores his commitment to fostering learning and academic excellence within the university setting.

Honor and Award:

Dr. Morteza Sadeghi has received recognition and honors for his academic achievements, including:

Member of Talented University of Kurdistan (2011-2015): Dr. Sadeghi has been acknowledged as a member of the Talented University of Kurdistan for a four-year period. This recognition highlights his academic excellence and contributions during his undergraduate studies.

Achievement in Regional Olympiad: He was recognized as the fourth-ranked participant in the 8-nation regional Olympiad. This achievement underscores his excellence in academic and possibly research-related endeavors, showcasing his commitment to intellectual pursuits.

Research Area:

Dr. Morteza Sadeghi has demonstrated expertise and engagement in diverse research areas within the field of biochemistry. His research areas include:

Design and Synthesis of Metal Complexes: Dr. Sadeghi has contributed to the design, synthesis, and characterization of Pd (II) NHC complexes. This work involves crystallography studies and explores the inhibitory properties of these complexes.

pH-Sensitive Microgels for Enzyme Inhibition: His research involves the development of pH-sensitive gelatin-based microgels for controlled release of bioactive compounds, particularly for inhibiting α-glucosidase. This work integrates experimental and computational studies.

Drug Design and Evaluation: Dr. Sadeghi has been involved in the synthesis and evaluation of quinazolin‐4(3H)‐one derivatives as multitarget metabolic enzyme inhibitors. This research aligns with biochemistry-oriented drug design principles.

Molecular Docking Studies: His work includes molecular docking studies of flavone analogues as inhibitors of α-Glucosidase. Molecular docking is a computational technique used to predict the binding affinity and orientation of ligands (compounds) to their target proteins.

Inhibitory Effects Against SARS-CoV-2: Dr. Sadeghi has conducted in silico studies to investigate the inhibitory effects of selected isoquinoline alkaloids against the main protease (Mpro) of SARS-CoV-2, the virus responsible for COVID-19.

These research areas showcase Dr. Morteza Sadeghi’s multidisciplinary approach, spanning from synthetic chemistry and biochemistry to computational methods. His work addresses both fundamental aspects of molecular interactions and practical applications in drug design and enzyme inhibition.

Publication Top Noted:

Dr. Morteza Sadeghi has made significant contributions to the field of biochemistry, as evidenced by his notable publications. Here are some of his key research works:

Title: Design, synthesis, characterization, crystal structure, in silico studies, and inhibitory properties of the PEPPSI type Pd (II) NHC complexes bearing chloro/fluorobenzyl group

  • Authors: Y Gök, P Taslimi, B Şen, S Bal, A Aktaş, M Aygün, M Sadeghi, İ Gülçin
  • Journal: Bioorganic Chemistry
  • Year: 2023
  • Citation Count: 12

Title: Control of eriocitrin release from pH-sensitive gelatin-based microgels to inhibit α-glucosidase: an experimental and computational study

  • Authors: M Sadeghi, M Sheikhi, M Miroliaei
  • Journal: Food & Function
  • Year: 2022
  • Citation Count: 11

Title: Synthesis and Evaluation of Quinazolin‐4(3H)‐one Derivatives as Multitarget Metabolic Enzyme Inhibitors: A Biochemistry‐Oriented Drug Design

  • Authors: FS Tokalı, P Taslimi, M Sadeghi, H Şenol
  • Journal: ChemistrySelect
  • Year: 2023
  • Citation Count: 10

Title: Molecular docking studies of some flavone analogues as α-Glucosidase inhibitors

  • Authors: M Sadeghi, MA Zarei
  • Journal: Journal of Medicinal Plants
  • Year: 2020
  • Citation Count: 10

Title: Inhibitory effects of selected isoquinoline alkaloids against main protease (Mpro) of SARS-CoV-2, in silico study

  • Authors: M Sadeghi, M Miroliaei
  • Journal: In Silico Pharmacology
  • Year: 2022
  • Citation Count: 6

These publications reflect Dr. Sadeghi’s involvement in diverse research areas, from the design of chemical compounds to the computational study of their inhibitory properties against enzymes. The citation counts indicate the impact and recognition of his work within the scientific community.